News | September 05, 2007

Cardiovascular Technologies Highlighted at Cleveland Clinic Medical Innovation Summit, Oct. 1-3

September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.
The summit will highlight the top 10 healthcare Innovations Cleveland Clinic clinicians and researchers expect to have a significant impact in 2008. The event also includes live surgeries to illustrate state of the art treatments for cardiovascular disease and in-depth debates on industry challenges.
This marks the fifth year Cleveland Clinic has hosted this international gathering of industry decision-makers to dissect advances revolutionizing healthcare and accelerate the application of life-saving cardiovascular technologies. The 2007 Medical Innovation Summit will draw 900 industry executives, entrepreneurs, venture capitalists and clinicians.
CCF Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CCF Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin-off companies, licensees and equity partnerships.

For more information: www.clevelandclinic.org

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Overlay Init